U.S. federal trademark · Serial No. 79098073 · Reg. No. 4140807
Polyvalent human immunoglobulin to be administered parenterally, subcutaneously or intravenously, by health care workers in hospitals and clinics, in outpatient clinics and during external consultations, in medical practices and by self-administration for the treatment of congenital or acquired immunodeficiencies or to provide immunomodulation
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.